tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jack Lin, 3 are a BUY (75%), 1 are a HOLD (25%).
Analyst Jack Lin, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 50% that have a potential upside of 8.93% achieved within 29 days.
Jack Lin’s has documented 8 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HCM, HUTCHMED DRC at 22-Sep-2025.
Analyst best performing recommendations are on HCM (HUTCHMED DRC).
The best stock recommendation documented was for HCM (HUTCHMED DRC) at 5/14/2024. The price target of $17.5 was fulfilled within 37 days with a profit of $3.9 (18.22%) receiving and performance score of 4.93.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Feb-2025
$17
$4.18 (32.61%)
$27
2 months 7 days ago
(07-Jul-2026)
1/3 (33.33%)
$5.92 (53.43%)
85
Buy Since 10-Mar-2026
$20
$9.83 (96.66%)
$28
6 months 4 days ago
(10-Mar-2026)
0/2 (0%)
$6.11 (43.99%)
Hold Since 22-Sep-2025
$13.75
$3.58 (35.20%)
$17.5
11 months 23 days ago
(22-Sep-2025)
2/2 (100%)
$-2.91 (-17.47%)
58
Buy Since 13-Mar-2020
$50
$34.76 (228.08%)
$50
3 years 9 days ago
(05-Sep-2023)
1/6 (16.67%)
$35.15 (236.70%)
477
Buy Since 23-Oct-2019
$11
$-4.24 (-27.82%)
$11
3 years 2 months 3 days ago
(11-Jul-2023)
2/3 (66.67%)
$-1.31 (-10.64%)
136
What Year was the first public recommendation made by Jack Lin?
